Biotech · Private company
SygNola, LLC
Track this companyFree. Adds SygNola, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials74 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials7
- Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot UlcersNA · RECRUITING · started Dec 4, 2025ClinicalTrials.gov NCT07161830 · fetched Nov 12, 2026
- Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure UlcersNA · RECRUITING · started Dec 1, 2025ClinicalTrials.gov NCT07158658 · fetched Nov 12, 2026
- Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open WoundsNA · RECRUITING · started Oct 16, 2025ClinicalTrials.gov NCT06918561 · fetched Nov 12, 2026
- Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot UlcersNA · RECRUITING · started Oct 6, 2025ClinicalTrials.gov NCT06938685 · fetched Nov 12, 2026
- Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg UlcersNA · COMPLETED · started Sep 2, 2025ClinicalTrials.gov NCT07061613 · fetched Nov 12, 2026
- Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot UlcersNA · COMPLETED · started Aug 26, 2025ClinicalTrials.gov NCT07039396 · fetched Nov 12, 2026
- Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open WoundsNA · COMPLETED · started Aug 25, 2025ClinicalTrials.gov NCT07041177 · fetched Nov 12, 2026